Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 107

Similar articles for PubMed (Select 23202893)

1.

Interferon-β1b increases Th2 response in neuromyelitis optica.

Nakajima H, Hosokawa T, Doi Y, Ikemoto T, Ishida S, Kimura F, Hanafusa T.

Int J Mol Sci. 2012 Sep 25;13(10):12213-23. doi: 10.3390/ijms131012213.

2.

Association of Th1/Th2-related chemokine receptors in peripheral T cells with disease activity in patients with multiple sclerosis and neuromyelitis optica.

Shimizu Y, Ota K, Kubo S, Kabasawa C, Kobayashi M, Ohashi T, Uchiyama S.

Eur Neurol. 2011;66(2):91-7. doi: 10.1159/000329576. Epub 2011 Aug 12.

PMID:
21846991
3.

Expression of chemokine receptors on peripheral blood lymphocytes in multiple sclerosis and neuromyelitis optica.

Uzawa A, Mori M, Hayakawa S, Masuda S, Nomura F, Kuwabara S.

BMC Neurol. 2010 Nov 11;10:113. doi: 10.1186/1471-2377-10-113.

4.

Cyclophosphamide modulates CD4+ T cells into a T helper type 2 phenotype and reverses increased IFN-gamma production of CD8+ T cells in secondary progressive multiple sclerosis.

Karni A, Balashov K, Hancock WW, Bharanidharan P, Abraham M, Khoury SJ, Weiner HL.

J Neuroimmunol. 2004 Jan;146(1-2):189-98.

PMID:
14698862
5.

Poor responses to interferon-beta treatment in patients with neuromyelitis optica and multiple sclerosis with long spinal cord lesions.

Wang KC, Lin KH, Lee TC, Lee CL, Chen SY, Chen SJ, Chin LT, Tsai CP.

PLoS One. 2014 Jun 2;9(6):e98192. doi: 10.1371/journal.pone.0098192. eCollection 2014.

6.

Time-dependent cytokine deviation toward the Th2 side in Japanese multiple sclerosis patients with interferon beta-1b.

Ochi H, Feng-Jun M, Osoegawa M, Minohara M, Murai H, Taniwaki T, Kira J.

J Neurol Sci. 2004 Jul 15;222(1-2):65-73.

PMID:
15240198
7.

Long-term favorable response to interferon beta-1b is linked to cytokine deviation toward the Th2 and Tc2 sides in Japanese patients with multiple sclerosis.

Mei FJ, Osoegawa M, Ochi H, Minohara M, Nan S, Murai H, Ishizu T, Taniwaki T, Kira J.

J Neurol Sci. 2006 Jul 15;246(1-2):71-7. Epub 2006 Mar 6.

PMID:
16581087
8.

Therapeutic efficacy of interferon β-1b in Japanese patients with optic-spinal multiple sclerosis.

Shimizu Y, Fujihara K, Kubo S, Takahashi T, Misu T, Nakashima I, Yokoyama K, Itoyama Y, Uchiyama S.

Tohoku J Exp Med. 2011;223(3):211-4.

9.
10.

Chemokine receptor expression on T cells in blood and cerebrospinal fluid at relapse and remission of multiple sclerosis: imbalance of Th1/Th2-associated chemokine signaling.

Misu T, Onodera H, Fujihara K, Matsushima K, Yoshie O, Okita N, Takase S, Itoyama Y.

J Neuroimmunol. 2001 Mar 1;114(1-2):207-12.

PMID:
11240033
11.

Interleukin-17-secreting T cells in neuromyelitis optica and multiple sclerosis during relapse.

Wang HH, Dai YQ, Qiu W, Lu ZQ, Peng FH, Wang YG, Bao J, Li Y, Hu XQ.

J Clin Neurosci. 2011 Oct;18(10):1313-7. doi: 10.1016/j.jocn.2011.01.031. Epub 2011 Jul 26.

PMID:
21795048
12.

Dynamic T-lymphocyte chemokine receptor expression induced by interferon-beta therapy in multiple sclerosis.

Krakauer M, Sorensen PS, Khademi M, Olsson T, Sellebjerg F.

Scand J Immunol. 2006 Aug;64(2):155-63.

PMID:
16867161
13.

C-C chemokine receptor 4 expression defines a major subset of circulating nonintestinal memory T cells of both Th1 and Th2 potential.

Andrew DP, Ruffing N, Kim CH, Miao W, Heath H, Li Y, Murphy K, Campbell JJ, Butcher EC, Wu L.

J Immunol. 2001 Jan 1;166(1):103-11.

14.

Interferon-beta(1b) treatment in neuromyelitis optica.

Tanaka M, Tanaka K, Komori M.

Eur Neurol. 2009;62(3):167-70. doi: 10.1159/000227277. Epub 2009 Jul 7.

PMID:
19590215
15.

IL-22 secreting CD4+ T cells in the patients with neuromyelitis optica and multiple sclerosis.

Xu W, Li R, Dai Y, Wu A, Wang H, Cheng C, Qiu W, Lu Z, Zhong X, Shu Y, Kermode AG, Hu X.

J Neuroimmunol. 2013 Aug 15;261(1-2):87-91. doi: 10.1016/j.jneuroim.2013.04.021. Epub 2013 May 28.

PMID:
23726764
16.

Differential expression of the chemokine receptors by the Th1- and Th2-type effector populations within circulating CD4+ T cells.

Yamamoto J, Adachi Y, Onoue Y, Adachi YS, Okabe Y, Itazawa T, Toyoda M, Seki T, Morohashi M, Matsushima K, Miyawaki T.

J Leukoc Biol. 2000 Oct;68(4):568-74.

17.

[Chemokines and chemokine receptors in multiple sclerosis].

Misu T, Fujihara K, Itoyama Y.

Nihon Rinsho. 2003 Aug;61(8):1422-7. Review. Japanese.

PMID:
12962033
18.

Expression of chemokine receptors on Th1/Th2 CD4+ lymphocytes in patients with multiple sclerosis.

Andalib A, Doulabi H, Najafi M, Tazhibi M, Rezaie A.

Iran J Immunol. 2011 Mar;8(1):1-10. doi: IJIv8i1A1.

PMID:
21427490
19.

Antibodies against interferon-beta in neuromyelitis optica patients.

Asgari N, Kyvik KO, Steenstrup T, Stenager E, Lillevang ST.

J Neurol Sci. 2014 Apr 15;339(1-2):52-6. doi: 10.1016/j.jns.2014.01.019. Epub 2014 Jan 17.

PMID:
24477087
20.

Expression of TH1/TH2-related chemokine receptors on peripheral T cells and correlation with clinical disease activity in patients with multiple sclerosis.

Nakajima H, Fukuda K, Doi Y, Sugino M, Kimura F, Hanafusa T, Ikemoto T, Shimizu A.

Eur Neurol. 2004;52(3):162-8. Epub 2004 Nov 2.

PMID:
15528917
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk